1. Home
  2. DRUG vs AREN Comparison

DRUG vs AREN Comparison

Compare DRUG & AREN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • AREN
  • Stock Information
  • Founded
  • DRUG 2019
  • AREN 2016
  • Country
  • DRUG United States
  • AREN United States
  • Employees
  • DRUG N/A
  • AREN N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • AREN Medical/Dental Instruments
  • Sector
  • DRUG Health Care
  • AREN Health Care
  • Exchange
  • DRUG Nasdaq
  • AREN Nasdaq
  • Market Cap
  • DRUG 345.6M
  • AREN 309.5M
  • IPO Year
  • DRUG N/A
  • AREN N/A
  • Fundamental
  • Price
  • DRUG $59.91
  • AREN $5.39
  • Analyst Decision
  • DRUG Strong Buy
  • AREN Strong Buy
  • Analyst Count
  • DRUG 9
  • AREN 1
  • Target Price
  • DRUG $81.67
  • AREN $12.00
  • AVG Volume (30 Days)
  • DRUG 106.1K
  • AREN 263.0K
  • Earning Date
  • DRUG 08-11-2025
  • AREN 11-13-2025
  • Dividend Yield
  • DRUG N/A
  • AREN N/A
  • EPS Growth
  • DRUG N/A
  • AREN N/A
  • EPS
  • DRUG N/A
  • AREN 2.74
  • Revenue
  • DRUG N/A
  • AREN $146,610,000.00
  • Revenue This Year
  • DRUG N/A
  • AREN $29.48
  • Revenue Next Year
  • DRUG N/A
  • AREN $11.72
  • P/E Ratio
  • DRUG N/A
  • AREN $2.16
  • Revenue Growth
  • DRUG N/A
  • AREN 6.81
  • 52 Week Low
  • DRUG $0.94
  • AREN $0.56
  • 52 Week High
  • DRUG $79.02
  • AREN $10.05
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 73.27
  • AREN 38.21
  • Support Level
  • DRUG $48.90
  • AREN $5.50
  • Resistance Level
  • DRUG $54.63
  • AREN $6.85
  • Average True Range (ATR)
  • DRUG 3.94
  • AREN 0.49
  • MACD
  • DRUG 0.80
  • AREN -0.02
  • Stochastic Oscillator
  • DRUG 90.58
  • AREN 12.24

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

Share on Social Networks: